Halcion Nights: A Sociological Account of a Medical Controversy
Authors:
- Jonathan GabeJGJonathan Gabe
- Michael BuryMBMichael Bury
- 1 August 1996
- journal article
- research article
- Published by SAGE Publications in Sociology
- Vol. 30 (3) , 447-469
Abstract
This paper offers an analysis of the events surrounding the suspension of the licence for the widely used sleeping tablet Halcion (triazolam) by the British Licensing Authority in October 1991. It is argued that these events highlight a growing crisis in modern medical treatments and in the social relations of health care. This is illustrated by focusing on four elements which have contributed to Halcion becoming a public issue and to its suspension and subsequent banning, namely the claims-making activities of medical experts, the development of legal challenges to medicine, the role of the media and the response of the state.Keywords
This publication has 26 references indexed in Scilit:
- Distributing the Benefit of the Doubt: Scientists, Regulators, and Drug SafetyScience, Technology, & Human Values, 1994
- Triazolam hearingThe Lancet, 1992
- Idiosyncratic side effects of short half-life benzodiazepine hypnotics: Fact or fancy?Human Psychopharmacology: Clinical and Experimental, 1992
- Safety of triazolamThe Lancet, 1991
- Mediating illness: newspaper coverage of tranquilliser dependenceSociology of Health & Illness, 1991
- Drug-company data and the public interestThe Lancet, 1991
- AIDS and the News MediaThe Milbank Quarterly, 1991
- TRIALS AND TRIBULATIONS OF TRIAZOLAMThe Journal of Clinical Pharmacology, 1980
- REACTIONS TO TRIAZOLAMThe Lancet, 1979
- Nitrazepam and the elderly.BMJ, 1972